Assessment of a Potential Synergistic Effect of Souvenaid ® in Mild Alzheimer’s Disease Patients on Treatment with Acetylcholinesterase Inhibitors: An Observational, Non-Interventional Study

Nutrients in the Prevention of Alzheimer’s Disease

(2019) Anna Laura Cremonini et al.   Oxidative Medicine and Cellular Longevity

The LipiDiDiet trial: what does it add to the current evidence for Fortasyn Connect in early Alzheimer’s disease?

(2019) Jill Rasmussen   Clinical Interventions in Aging

Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial

(2018) Philip Scheltens et al.   JOURNAL OF ALZHEIMERS DISEASE

24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial

(2017) Hilkka Soininen et al.   LANCET NEUROLOGY

Practice guideline update summary: Mild cognitive impairment

(2017) Ronald C. Petersen et al.   NEUROLOGY

Effect Size Analyses of Souvenaid in Patients with Alzheimer’s Disease

(2016) Jeffrey Cummings et al.   JOURNAL OF ALZHEIMERS DISEASE

The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study

(2014) Hanneke de Waal et al.   PLoS One

Plasma nutrient status of patients with Alzheimer's disease: Systematic review and meta-analysis

(2013) Sofia Lopes da Silva et al.   Alzheimers & Dementia

A review on cholinesterase inhibitors for Alzheimer’s disease

(2013) Preet Anand et al.   ARCHIVES OF PHARMACAL RESEARCH

The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease

(2013) Raj C Shah et al.   Alzheimers Research & Therapy

Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial

(2010) Philip Scheltens et al.   Alzheimers & Dementia